PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24056738-7	2014	CD20Bi aATC infusions induced specific cytotoxicity directed at lymphoma targets.	aatc	7-11	keratin 20	Homo sapiens	0-4	
23529012-1	2013	A phase I trial of infusing anti-CD3 x anti-CD20 bispecific antibody (CD20Bi) armed activated T cells (aATC) was conducted in high-risk/refractory non-Hodgkin"s lymphoma patients to determine whether aATC infusions are safe, affect immune recovery, and induce an antilymphoma effect.	aatc	103-107	keratin 20	Homo sapiens	44-48